Use access key #2 to skip to page content.
$21.89 0.21 (0.97%)
7/23/2008 4:01 PM

Bristol-Myers Squibb Co. (BMY)

CAPS Rating:
****

The Company, through its divisions and subsidiaries, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other health care related products.

View All Commentary (BMY)

Recs

5

Avatar jim001x (49.73) Submitted: 3/23/08 8:23 PM : Outperform Start Price: $20.89 BMY Score: 8.62

At 21.46 BMY is trading close to its 52 week low with a 5.78% DY.


Last Morningstar fair value estimates were $26 and 23. S&P has a $26 target price.


BMY Was recommended by Chuck Carlson with Quadrix 1st of the year and gone down since like many others. i'll be getting paid to wait for it to come back and if it goes up $1 that's another 5%.


Fundamentally, has lowest P/S and highest 5 year EPS growth over


next 5 years among its peers.

Report this Post Replies: 1 | Reply

Avatar ArmChairQB (< 20) Submitted: 6/20/08 9:11 AM

Recs: 0 | Rec This

Good Call. With the lower P/E and strong dividend it is like buying a CD with appreciation potential. Solid!

Report this Post Reply

Featured Broker Partners